Autigen

Autigen, a subsidiary of Otologic Pharmaceutics, is a biotechnology company developing new therapies for patients with acute and chronic hearing loss. The company's research is based on scientific studies conducted by the House Ear Institute (HEI), aiming to develop new treatments to restore hearing loss. The company’s technology platform can regenerate lost hair cells (HC) in the ear. The therapeutic agents can be administered intratympanically in an outpatient setting.